Dr. Zafar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-648-8765Fax+1 214-645-8769
Education & Training
- Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Urologic Surgical Oncology, 2021 - 2023
- Washington University/B-JH/SLCH ConsortiumResidency, Urology, 2016 - 2021
- Baylor College of MedicineClass of 2016
Certifications & Licensure
- TX State Medical License 2023 - 2025
- MA State Medical License 2021 - 2024
- MO State Medical License 2016 - 2021
Publications & Presentations
PubMed
- Surgical Outcomes of Radical Nephrectomy and Inferior Vena Cava Thrombectomy Following Preoperative Systemic Immunotherapy: A Propensity Score Analysis.Zine-Eddine Khene, Raj Bhanvadia, Isamu Tachibana, Wadih Issa, William Graber
Clinical Genitourinary Cancer. 2025-01-21 - 4 citationsAndrogen deprivation therapy for prostate cancer and neurocognitive disorders: a systematic review and meta-analysis.David E Hinojosa-Gonzalez, Affan Zafar, Gal Saffati, Shane Kronstedt, Dimitar V Zlatev
Prostate Cancer and Prostatic Diseases. 2024-09-01 - 11 citationsSequential intravesical gemcitabine/docetaxel provides a durable remission in recurrent high-risk NMIBC following BCG therapy.Kendrick Yim, Kevin Melnick, Sarah L Mott, Filipe L F Carvalho, Affan Zafar
Urologic Oncology. 2023-11-01
Press Mentions
- Bladder Cancer Trimodal Therapy’s Effects on Long-Term Renal Function DescribedApril 30th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: